Latest Loan Repayment News

Fluence Corporation Limited reported a positive net operating cash flow of US$5.1 million for Q2 2025, boosting its cash reserves to US$12.7 million and maintaining solid liquidity through revolving credit and loan facilities.

Peppermint Innovation Ltd reported robust growth in registered users, loan approvals, and transaction volumes in its June 2025 quarter, alongside strategic partnerships and key platform upgrades aimed at expanding financial inclusion in the Philippines.

Locality Planning Energy Holdings has appointed Craig Chambers as Chairman and reported a cashflow positive year, reaffirming a net profit guidance of $3.0 to $3.5 million for FY25.

Nickel Industries reported record ore sales and EBITDA at its Hengjaya Mine for the June 2025 quarter, alongside significant progress on key projects and sustainability initiatives.

Entertainment Rewards Ltd reports a 6.1% revenue increase in Q4 FY25, driven by growth in key programs and a new $2.5 million loan facility, while narrowing its operating loss.

Clever Culture Systems advances its pharmaceutical market penetration with AstraZeneca’s full deployment and Novo Nordisk’s first order, while launching a new contact plate analysis module that doubles its APAS Independence system’s capabilities.

Spacetalk Ltd reports robust growth in paid mobile subscribers and recurring revenue for Q4 FY25, supported by strategic capital raises and international expansion.

Multistack International has announced the discontinuation of its current business operations following a significant asset sale that settled a $3.55 million loan, signaling a major strategic shift for the company.

Multistack International Limited reported a net cash outflow for the quarter ending June 2025 but has strengthened its balance sheet through major loan repayments and is progressing acquisition discussions with SuperLink.

Kingston Resources Limited reported a positive operating cash flow for the June 2025 quarter, ending with AUD 6.25 million in cash and a solid funding runway supported by a secured loan facility.

Zelira Therapeutics has locked in a $650,000 loan facility secured against its anticipated FY25 R&D tax rebate, aiming to accelerate its HOPE SPV clinical trial and strengthen working capital.

Deep Yellow Limited reported a quarterly operating cash outflow of A$6.3 million but ended June 2025 with a strong cash position of A$217 million, providing a runway of 24 quarters at current spending levels.